Trials / Completed
CompletedNCT03602755
A Study of the First-line Treatment of Patients With Newly Diagnosed Transplant-ineligible Multiple Myeloma in Spain
Retrospective Study of the First-line Treatment of Patients With Newly Diagnosed Transplant-ineligible Multiple Myeloma Between 2012 and 2016, Treated According to Routine Clinical Practice in Spain
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 706 (actual)
- Sponsor
- Celgene · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an observational, post-authorization, retrospective, multicenter study (PAS-OD) that will be conducted in approximately 20 centers in Spain. In all cases, only data recorded prior to the date of study start will be collected to ensure its retrospective nature, thus reflecting real clinical practice, avoiding any influence on the physician's clinical practice.
Conditions
Timeline
- Start date
- 2018-07-19
- Primary completion
- 2019-01-18
- Completion
- 2019-01-18
- First posted
- 2018-07-27
- Last updated
- 2019-02-04
Locations
20 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT03602755. Inclusion in this directory is not an endorsement.